This association remained after excluding donors who had co-morbid AD and FTLD, suggesting unique contribution from CTE and this is consistent with research showing the molecular composition of p-tau is distinct from AD and FTLD [47, 50, 51]. Here, MAPT is linked to Alzheimer disease.